BIOS Fund II, LP → IN8BIO, INC. INAB

Stake: 4.00% Shares: 391,357 CUSIP: 45674E109 Class: Common Stock, par value $0.0001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

32,797 shares short · -29.4% vs prior

Post-Filing Returns · since 2025-12-22 on INAB

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 1.39 on closest trading day on/after 2025-12-22. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on IN8BIO, INC.

Filed	Form	Filer	Stake	Shares
2026-05-29	SCHEDULE 13D/A	FAIRBAIRN EMILY	2.20%	215,431	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →